# Vitrectomy Combined With Intravitreal Dexamethasone Implant for Idiopathic Epiretinal Membrane With Macular Oedema

> **NCT06232616** · NA · ENROLLING_BY_INVITATION · sponsor: **Shanghai Eye Disease Prevention and Treatment Center** · enrollment: 20 (estimated)

## Conditions studied

- Epiretinal Membrane

## Interventions

- **PROCEDURE:** vitrectomy combined with intravitreal dexamethasone implant

## Key facts

- **NCT ID:** NCT06232616
- **Lead sponsor:** Shanghai Eye Disease Prevention and Treatment Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-03-11
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06232616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06232616, "Vitrectomy Combined With Intravitreal Dexamethasone Implant for Idiopathic Epiretinal Membrane With Macular Oedema". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06232616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*